| abstract |
The present invention provides a method for preventing, ameliorating or treating a liver disease comprising hepatitis, cirrhosis, fatty liver, liver failure and liver cancer. Ginsenoside F2 suppresses adipogenesis and accumulation in the liver, increases the distribution of regulatory T cells that suppress the activity of inflammatory cells, protects hepatitis, and is an anti-inflammatory cytokine in regulatory T cells It is possible to increase IL-10 expression, suppress differentiation into Th17 cells in naive T cells, and effectively treat various liver diseases. Pharmaceutical compositions, functional foods, and feed compositions using ginsenoside F2 are also provided. [Selection] Figure 1 |